GGrantIndex
← Search

REDIRECTING ENGINEERED T CELLS USING A SMALL MOLECULE DRUG: A NOVEL APPROACH FOR THE TREATMENT OF METASTATIC PROSTATE CANCER

$307,632FY2015Department of DefenseDOD

California Institute For Biomedical Research, The

Investigators

View source on USAspending →
REDIRECTING ENGINEERED T CELLS USING A SMALL MOLECULE DRUG: A NOVEL APPROACH FOR THE TREATMENT OF METASTATIC PROSTATE CANCER · GrantIndex